Brief: ReShape Lifesciences Receives NASDAQ Notice On Not Regaining Compliance With Minimum Bid Price Requirement
10/04/2024 23:02
April 10 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES - ON APRIL 9, RECEIVED WRITTEN NOTICE
FROM
NASDAQ STAFF THAT CO HAS NOT REGAINED COMPLIANCE WITH MINIMUM
BID PRICE REQUIREMENT
Source text for Eikon: ID:n0001558370-24-004933
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity